Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | NOS2 | P35228 | 1/20 | 0.52 |
| ▸ | BACE1 | P56817 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 5/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | MGAM | O43451 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | AR | P10275 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14127532 | 1.00 | NCF1 (0.52) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL29427043 | 1.00 | NCF1 (0.52) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL28914737 | 0.97 | NCF1 (0.50) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL6347887 | 0.97 | NCF1 (0.50) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL4868283 | 0.84 | TDP1 (0.52) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL28901057 | 0.80 | RAB9A (0.38) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL7512795 | 0.80 | GPBAR1 (0.43) | NCF1CYP1A2MAPK1CYP3A4CYP2C9 | |
| SCHEMBL30121602 | 0.78 | RAB9A (0.49) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL12446780 | 0.78 | RAB9A (0.49) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL12982905 | 0.74 | NCF1 (0.52) | NCF1CYP1A2NOS2BACE1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119285543-B | Sulfonylation method of halogenated quinoline and aryl sulfonyl hydrazine | 南京工业大学 | 2026-05-15 | — | — | CN | claimed |
| CN-120192316-A | Biphenyl indoloquinoline structural compound, preparation method and OLED device | 成都维拓立柔性电子技术有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119823038-A | Catalyst, preparation method and application thereof | 万华化学集团股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119285543-A | Sulfonylation method of halogenated quinoline and aryl sulfonyl hydrazine | 南京工业大学 | 2025-01-10 | — | — | CN | claimed |
| CN-119101915-A | Method for constructing benzoxazole [3,2-a ] quinoline salt by utilizing electrochemical oxidative coupling reaction | 桂林理工大学 | 2024-12-10 | — | — | CN | claimed |
| CN-118239950-A | Biphenyl indoloquinoline structural compound, preparation method and OLED device | 成都维拓立柔性电子技术有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-117865932-A | Preparation method of benzothiophene sulfone compound with medicinal and fluorescent activity | 北京化工大学 | 2024-04-12 | — | — | CN | claimed |
| US-20240010619-A1 | SMALL MOLECULES WITH ANTIBACTERIAL ACTIVITY | NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION | 2024-01-11 | — | — | US | claimed |
| CN-116751221-A | Preparation method and application method of novel quinoline-2-borate | 西安欧得光电材料有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-114958342-A | Three-component doped luminescent material with adjustable phosphorescence performance and preparation method thereof | 温州大学新材料与产业技术研究院 | 2022-08-30 | — | — | CN | claimed |
| CN-102190676-A | Method and apparatus for continuously producing aryl boric acid | BAYER TECHNOLOGY AND ENGINEERING SHANGHAI COMPANY LTD | 2011-09-21 | — | — | CN | claimed |
| CN-101948366-A | Method for preparing 4- (diphenylamino) biaryl compound in water phase | UNIV DALIAN TECH | 2011-01-19 | — | — | CN | claimed |
| CN-101293961-A | Electrochromic polymeric compounds, preparing method and application thereof | UNIV ZHEJIANG TECHNOLOGY (CN) | 2008-10-29 | — | — | CN | claimed |
| US-6713615-B2 | Process for producing erythromycin derivative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-03-30 | — | — | US | claimed |
| US-20030191295-A1 | Process for producing erythromycin derivative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2003-10-09 | — | — | US | claimed |
| CN-1446224-A | Process for producing erythromycin derivative | TAISHO PHARMACEUTICAL CO LTD (JP) | 2003-10-01 | — | — | CN | claimed |
| EP-1310506-A1 | PROCESS FOR PRODUCING ERYTHROMYCIN DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2003-05-14 | — | — | EP | claimed |
| EP-0365863-B1 | Novel quinolyloxazole-2-ones useful as proteinkinase C inhibitors | MERRELL DOW PHARMA (US) | 1994-08-17 | — | — | EP | claimed |
| CN-1042145-A | New quinolyl azoles-2-ketone compounds as inhibitors of protein kinase C | MERRELL DOW PHARMA (US) | 1990-05-16 | — | — | CN | claimed |
| EP-0365863-A2 | Novel quinolyloxazole-2-ones useful as proteinkinase C inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-05-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240010619-A1 | SMALL MOLECULES WITH ANTIBACTERIAL ACTIVITY | CLPP, MRPL21, TIAL1 | NCF1 346/4885CYP1A2 4409/4885NOS2 1529/4885 |
| US-20030191295-A1 | Process for producing erythromycin derivative | CYP51A1, ERG28, ELOVL6 | NCF1 3551/4885CYP1A2 530/4885NOS2 1269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.